RANKL (TNFSF11)

RANKL (TNFSF11)

RANKL (Receptor Activator of Nuclear Factor Kappa-B Ligand), also known as TNFSF11 or TRANCE, is a cytokine that belongs to the tumor necrosis factor superfamily. It plays essential roles in bone metabolism, immune system regulation, and has been implicated in neuroinflammatory processes underlying neurodegenerative diseases.

Gene Overview

<div class="infobox infobox-gene">
| Property | Value |
|----------|-------|
| Gene Symbol | RANKL (TNFSF11) |
| Full Name | Tumor Necrosis Factor Ligand Superfamily Member 11 |
| Chromosomal Location | 13q14 |
| NCBI Gene ID | 9600 |
| OMIM | 602642 |
| Ensembl | ENSG00000120659 |
| UniProt | O14788 |
| Associated Diseases | Osteoporosis, rheumatoid arthritis, bone metastasis, neuroinflammation |
</div>

Overview

RANKL (TNFSF11)

RANKL (Receptor Activator of Nuclear Factor Kappa-B Ligand), also known as TNFSF11 or TRANCE, is a cytokine that belongs to the tumor necrosis factor superfamily. It plays essential roles in bone metabolism, immune system regulation, and has been implicated in neuroinflammatory processes underlying neurodegenerative diseases.

Gene Overview

<div class="infobox infobox-gene">
| Property | Value |
|----------|-------|
| Gene Symbol | RANKL (TNFSF11) |
| Full Name | Tumor Necrosis Factor Ligand Superfamily Member 11 |
| Chromosomal Location | 13q14 |
| NCBI Gene ID | 9600 |
| OMIM | 602642 |
| Ensembl | ENSG00000120659 |
| UniProt | O14788 |
| Associated Diseases | Osteoporosis, rheumatoid arthritis, bone metastasis, neuroinflammation |
</div>

Overview

RANKL is a human gene whose product rANKL is a type II transmembrane protein that can exist in both membrane-bound and soluble forms["@lacey1998"]. It functions as the primary regulator of osteoclastogenesis and modulates immune responses:. Variants in RANKL have been implicated in Neurodegeneration, Musculoskeletal, Cancer. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.

Normal Function

RANKL is a type II transmembrane protein that can exist in both membrane-bound and soluble forms[@lacey1998]. It functions as the primary regulator of osteoclastogenesis and modulates immune responses:

Bone Metabolism

• Osteoclast Formation: RANKL binds to RANK on osteoclast precursors, triggering the [NF-κB](/entities/nf-kb), c-Fos, and NFATc1 signaling cascades that drive differentiation into mature osteoclasts[@kong1999]
• Bone Remodeling: The RANKL/OPG ratio determines bone resorption rates
• Pathological Bone Loss: Elevated RANKL contributes to conditions like osteoporosis and rheumatoid arthritis

Immune Regulation

• T Cell Co-stimulation: RANKL provides critical co-stimulatory signals for T cell activation and survival[@josien1999]
• Dendritic Cell Function: Promotes dendritic cell survival and migration
• Lymphoid Organogenesis: Essential for formation of lymph nodes and medullary thymic epithelial cells

CNS Functions

• Microglial Activation: Soluble RANKL can activate [microglia](/cell-types/microglia-neuroinflammation), promoting production of pro-inflammatory cytokines
• Synaptic Plasticity: Emerging evidence suggests RANKL may modulate synaptic function
• [Blood-Brain Barrier](/entities/blood-brain-barrier): RANKL may influence BBB permeability during inflammation

Disease Associations

Neurodegeneration

• Alzheimer's Disease: Elevated RANKL levels in CSF and brain tissue correlate with disease progression. RANKL promotes microglial activation and neuroinflammation[@liu2022]
• Parkinson's Disease: RANKL may contribute to dopaminergic neuron loss through neuroinflammation
• Multiple Sclerosis: RANKL drives inflammatory bone erosion and CNS demyelination
• ALS: Altered RANKL signaling observed in ALS patients

Musculoskeletal

• Osteoporosis: High RANKL/OPG ratio leads to excessive bone resorption
• Rheumatoid Arthritis: Synovial fibroblasts produce RANKL, driving bone erosion

Cancer

• Bone Metastases: Tumor cells often express RANKL to promote osteolysis and metastasis
• Multiple Myeloma: Malignant plasma cells hijack RANKL for survival

Expression Pattern

RANKL is expressed in various tissues:

• High Expression: Lymph nodes, thymus, bone marrow, spleen
• Moderate Expression: Heart, skeletal muscle, brain
• Cellular Sources: Activated T cells, B cells, osteoblasts, fibroblasts, endothelial cells

Therapeutic Implications

Approved Therapies

• Denosumab: Monoclonal antibody against RANKL, approved for osteoporosis and bone metastases
• OPG-Fc: Recombinant osteoprotegerin as decoy receptor

Research Directions

• Blocking RANKL to reduce neuroinflammation in AD/PD
• Understanding RANKL's role in synaptic dysfunction
• Targeting RANKL in microglia for neuroprotection

Cross-Links

• [RANK (TNFRSF11A)](/genes/rank) - Receptor
• [OPG (TNFRSF11B)](/genes/tnfrsf11b) - Decoy receptor
• [TREM2](/genes/trem2) - Microglial activation
• [NF-κB](/mechanisms/nf-kappa-b) - Signaling pathway
• [Microglia](/cell-types/microglia) - CNS cells

See Also

• [NF-κB](/mechanisms/nf-kappa-b)

External Links

• [Ensembl: ENSG00000120659](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000120659)
• [NCBI Gene: RANKL](https://www.ncbi.nlm.nih.gov/gene/?term=RANKL)
• [GeneCards: RANKL](https://www.genecards.org/cgi-bin/carddisp.pl?gene=RANKL)
• [OMIM: RANKL](https://omim.org/search?search=RANKL)
• [Allen Brain Atlas: RANKL](https://human.brain-map.org/microarray/search/show?search_term=RANKL)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving RANKL (TNFSF11) discovered through SciDEX knowledge graph analysis: